Navigation Links
Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
Date:11/9/2010

esponse and was well tolerated. Vaccine-related serious side-effects which would raise any safety concern were not observed. The results provide a strong basis for evaluation of further development options. Intercell and its partner Novartis will determine next steps.

Clostridium difficile program planned to enter clinic: After successful pre-clinical trials, Intercell is progressing its vaccine candidate to prevent infections with Clostridium difficile (C. diff). C. diff is the leading cause for nosocomial Diarrhea in Europe and the U.S. A Phase I clinical study is expected to start in 2010.

Staphylococcus aureus vaccine (V710) on track: The Phase II/III study conducted and funded by Merck & Co., Inc. in cardiothoracic surgery patients for the investigational S. aureus vaccine is progressing to plan. The first critical interim analysis (surpassing futility) is expected in 2011.

Good progress in development pipeline – programs progressing according to plan

  • Recruitment for the pivotal Phase III study of approximately 2,000 travelers for Intercell's investigational Travelers' Diarrhea (TD) Vaccine Patch is completed. The first data from that trial, conducted in travelers to Mexico and Guatemala, is expected for end 2010/early 2011. The enrollment of a complementary 800-traveler Phase II study in those travelling to India has also been completed; first data is expected in Q4 2010. The trial in India is the first study outside South America and has the potential to demonstrate proof of concept for the vaccine in Asia.
  • Intercell will pursue activities with GSK to prepare markets as soon as data on Phase II and Phase III trials becomes available. Diarrhea is the most common health problem among travelers from developed countries who visit developing areas and most of the diarrheal cases in travelers are caused by bacteria, primarily by ETEC strains (Escherichia coli).
  • Intercell and GSK will continue de
    '/>"/>

  • SOURCE Intercell AG
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
    2. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
    3. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
    4. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
    5. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
    6. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
    7. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
    8. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
    9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
    10. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
    11. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/21/2015)... SAN FRANCISCO , April 21, 2015   ... focusing on the advancement of cardiac care, announced today ... care systems in the U.S., will now be offering ... of long-term continuous cardiac monitoring. "At Banner ... by improving patient outcomes and services," said John ...
    (Date:4/21/2015)... , April 21, 2015  Decision Diagnostics Corp. ... and the exclusive worldwide sales, service and regulatory ... FDA-cleared Green Alternative Strip, specifically designed to work ... OneTouch Ultra family of glucose testing meters, the ... today that Johnson & Johnson/Lifescan has requested an ...
    (Date:4/21/2015)... , April 21, 2015  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... on Tuesday, April 28, 2015.  On that day, the ... at 10:00 a.m. Eastern Time to discuss the results, ... Pat Mackin , Chairman, President and Chief Executive ...
    Breaking Medicine Technology:Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3CryoLife Announces Release Date and Teleconference Call Details for 2015 First Quarter Financial Results 2
    ... -- Chindex International, Inc. (NASDAQ: ... care services in China through the operations of United ... and affiliated ambulatory clinics, today announced that the Company ... and first half of 2011, which ended June 30, ...
    ... Apnex Medical, Inc., received investigational device exemption (IDE) approval ... begin a clinical study to evaluate the safety and ... treat obstructive sleep apnea (OSA). Data from this clinical ... application for the HGNS System to the FDA. ...
    Cached Medicine Technology:Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 3
    (Date:4/21/2015)... The International Journal of Chronic Obstructive Pulmonary ... and its association with smoking in the Mainland China: ... from ten diverse areas ”. , As corresponding author ... of the world’s cigarettes, but the substantial increases in ... for the full eventual health consequences to be seen. ...
    (Date:4/21/2015)... Francisco, CA and Orlando, FL (PRWEB) April 21, ... Behavioral Health (National Council) will honor Dina Tyler, ... Services for PREP (Prevention and Recovery in Early ... National Council Award of Excellence: Peer Specialist of ... awards ceremony, known as the Oscars of behavioral ...
    (Date:4/21/2015)... Among parents of children with autism ... as fair or poor, according to a study in ... a visit to the dentist can present many challenges ... the strange smells, loud noises, and sharp tools; the ... of the whole process—not knowing what will happen and ...
    (Date:4/21/2015)... The report “Sinusitis – ... on the therapeutic development for Sinusitis. The ... targets and MOAs to produce first-in-class and ... available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html . , ... in the therapeutic development for Sinusitis and ...
    (Date:4/21/2015)... April 21, 2015 Wireless Analytics, ... has been recognized by the Boston Business Journal as ... ranking was announced at a recent event celebrating the ... of the fastest-growing private companies in Massachusetts. , Wireless ... the state that recorded the fastest revenue growth from ...
    Breaking Medicine News(10 mins):Health News:COPD and smoking in the Mainland China published by Dove Medical Press 2Health News:COPD and smoking in the Mainland China published by Dove Medical Press 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 2Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2
    ... NY) The American Association for Cancer Research (AACR), ... awarded Susan Band Horwitz, Ph.D. , the Rose ... molecular pharmacology at Albert Einstein College of Medicine ... Achievement in Cancer Research. Dr. Horwitz, who is ...
    ... HealthDay Reporter , WEDNESDAY, Feb. 9 (HealthDay News) ... build-up in the lungs of heart failure patients and alerts ... device reduces hospitalizations and improves quality of life for these ... pressure in the lungs that causes symptoms such a shortness ...
    ... innovative model of dementia care developed by researchers at ... Institute significantly reduces emergency department visits and hospitalizations, and ... older brains. The result is improved health for older ... according to a paper evaluating the model in real ...
    ... are twice as likely to have poor health if they ... new study by researchers at St. Michael,s Hospital. ... are significantly higher in poorer neighbourhoords. "But this research shows ... how strongly they are affected," said Heather White, a researcher ...
    ... you don,t like shots or needles, you,re in luck. New ... http://www.fasebj.org ) gives the development of new oral vaccinations a ... glands of mice. In addition, this research report also offers ... mucosal surfaces, even if direct injections into the body fail ...
    ... , THURSDAY, Feb. 10 (HealthDay News) -- Low levels ... with higher rates of obesity, researchers report. The finding ... cities tend to be thinner because they have more opportunities ... to drive most everywhere they go. For this study, ...
    Cached Medicine News:Health News:Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research 2Health News:Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research 3Health News:Wireless Device Can Cut Heart Failure-Related Hospitalizations 2Health News:Wireless Device Can Cut Heart Failure-Related Hospitalizations 3Health News:New mode of dementia care improves health, lowers hospitalization rates 2Health News:Coastal Canadians living in high-risk neighborhoods in poorer health: Study 2Health News:Salivary glands as organs of immunity: New research makes oral immunization easier to swallow 2
    The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
    ... has expanded memory capabilities for overnight sleep screening., ... oxygen saturation and pulse rate data, and can ... your needs:, ,1. The Model 130 can ... a single patient, making the device ideally suited ...
    ... Cost-effective, portable, continuous, or ... system with alarms and an ... Home-Use and Sleep Study modes ... in the hospital or clinical ...
    ... The Autocorr Plus, the fourth in ... versatile pulse oximeter/ECG/Respiration Monitor, with 3 ... digital oximetry with SAC (Serial Autocorrelation) ... electroluminescent screen display provides two user ...
    Medicine Products: